BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7102998)

  • 1. The use of theophylline clearance to design an oral aminophylline regimen.
    Simmons SM; Camp RB; Mungall DR; Bailey WC
    Ala J Med Sci; 1982 Apr; 19(2):142-6. PubMed ID: 7102998
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J; Mirtallo JM; Altman M
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 7. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of theophylline clearance in determining maintenance intravenous aminophylline therapy.
    Grambau GR; Johnson CE; Conlon PF; Weg JG
    J Clin Pharmacol; 1985; 25(5):381-3. PubMed ID: 4031115
    [No Abstract]   [Full Text] [Related]  

  • 9. Doses of aminophylline given intravenously in casualty department and resulting serum theophylline concentrations.
    Munro CS; Prowse K
    Br Med J (Clin Res Ed); 1984 Aug; 289(6441):354-5. PubMed ID: 6432095
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC; Chai H; Miles-Lawrence R; Bell TD; Pinney CT
    Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
    Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
    Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities for optimizing therapy with theophylline preparations. III. Ventilatory effect and pharmacokinetics of "new" Pulmophyllin].
    Kandt D; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):18-25. PubMed ID: 6719956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theophylline serum levels and theophylline clearance in asthmatic patients (author's transl)].
    Pastor MC; Sabaté I; Torres JM; Corominas M; Fortuny M; Planells P
    Med Clin (Barc); 1982 Jul 1-31; 79(3):126-8. PubMed ID: 7109768
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral aminophylline therapy. Increased dosage requirements in children.
    Zaske DE; Miller KW; Strem EL; Austrian S; Johnson PB
    JAMA; 1977 Apr; 237(14):1453-5. PubMed ID: 576637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of the pharmacokinetic determination of theophylline].
    Gao L
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):137-40, 188. PubMed ID: 3094865
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of enoxacin on theophylline pharmacokinetics].
    Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):106-8, 128. PubMed ID: 1394590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring serum concentrations of theophylline during aminophylline infusion therapy].
    Prazáková J; Vondra V
    Cas Lek Cesk; 1985 Oct; 124(43):1332-5. PubMed ID: 4084951
    [No Abstract]   [Full Text] [Related]  

  • 18. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral aminophylline on lung mucociliary clearance in man.
    Sutton PP; Pavia D; Bateman JR; Clarke SW
    Chest; 1981 Dec; 80(6 Suppl):889-92. PubMed ID: 7030662
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral aminophylline and dikydroxypropyl theophylline in reversible obstructive airway disease: a single-dose, double-blind, crossover comparison.
    Hudson LD; Tyler ML; Petty TL
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):367-72. PubMed ID: 4198297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.